Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence

Alcohol and Alcoholism

Volumn 43, Issue 6, 2008, Pages 661-668

  Neto, Domingos ^a   Lambaz, Rita ^b   Aguiar, Pedro ^c   Chick, Jonathan ^d  

^a Princípio Actividades Médicas ^*  (Portugal)

^b IDT   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALANINE AMINOTRANSFERASE; ANTIDEPRESSANT AGENT; ASPARTATE AMINOTRANSFERASE; BUSPIRONE; DIAZEPAM; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; MIRTAZAPINE; SERTRALINE; TIAPRIDE; VENLAFAXINE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLICS ANONYMOUS; ALCOHOLISM; ARTICLE; BLOOD ANALYSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; ERYTHROCYTE VOLUME; FAMILY RELATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; TREATMENT DURATION;

ADULT; ALCOHOLISM; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TAURINE; TEMPERANCE;

EID: 55149110592     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agn075     Document Type: Article

References (27)

1. Aguiar P. (2007) Guia prático Climepsi de estatística em investigação epidemiológica. Climepsi Editores, Lisboa.
2. Altman. (1991) Practical Statistics for Medical Research. London: Chapman & Hall.
3. American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association.
4. Azrin NH. (1976) Improvements in the community-reinforcement approach to alcoholism. Behav Res Ther 14:339-48.
5. Azrin NH, Sisson RW, Meyers R et al. (1982) Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatry 13:105-12.
6. Barrias JA, Chabac S, Ferreira L et al. (1997) Acamprosato: Estudo Português Multicêntrico de Avaliação da Eficácia e Tolerância. Psiquiatria Clínica 18:149-60.
7. Brewer C, Meyers R, Johnsen J. (2000) Does disulfiram help to prevent relapse in alcohol abuse? Curr Opin CNS Drugs 14:329-41.
8. Buri C, Moggi F, Giovnoli A et al. (2007) Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland. Alcohol Alcohol 42 333-9.
9. Chick J. (1999) Safety issues concerning the use of dissulfiram in treating alcohol dependence. Drug Saf 20:427-35.
10. Chick J, Gough K, Wojciech F. (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161:84-9.
11. David M, Geada M, Neto D. (1998) Follow-up of 101 heroin addicts over one year of treatment with naltrexone and a family approach. Arquivos de Medicina 12:163-6.
12. David M, Neto D. (1997) Os fundamentos e as indicações do Tratamento Combinado e por Etapas de Heroinodependentes em Ambulatório. Acta Médica Portuguesa 12:905-9.
13. De Sousa A, De Sousa A. (2004) A one-year pragmatic trial of naltrex-one vs DIS in the treatment of alcohol dependence. Alcohol Alcohol 39:528-31.
14. De Sousa A, De Sousa A. (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-8.
15. Fuller RK, Branchey L, Brightwell DR. (1986) Disulfiram treatment of alcoholism: A veterans administration cooperative study. JAMA 256:1449-55.
16. Gameiro A. (1998) Hábitos; de consumo de bebidas alcoólicas em Portugal - 1985, 1991, 1997. Editorial Hospitalidade, Lisbon.
17. Gillings D, Koch G. (1991) The application of the principle of intention to treat to the analysis of clinical trials. Drug Inf J 25 411-24.
18. Graffard M. (1956) Une methode de classification sociale d'echantillons de population. Courrier de l'Unesco 6:455.
19. Hughes JC, Cook CCH. (1997) The efficacy of disulfiram: A review of outcomes stadies. Addiction 92:381-395.
20. Laaksonen E, Koski-Janës A, Salaspuro M et al. (2007) A randomized, multicentre, open-label, comparative trial of dissulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53-61.
21. Neto D, Xavier M, Aguiar P et al. (1997) Sequential combined treatment of heroin addicted patients in Portugal with naltrexone and family therapy. Eur Addict Res 3:129-37.
22. Patience D, Buxton M, Chick J et al. (1997) The SECCAT Survey: II. The alcohol related problems questionnaire as a proxy for resource costs and quality of life in alcoholism treatment. Alcohol Alcohol 32 79-84
23. Slattery J, Chick J, Cochrane M et al. (2003) Prevention of Relapse in Alcohol Dependence. Health Technology Assessment Report 3. Glasgow. Health Technology Board for Scotland.
24. Smith JE, Meyers RJ, Miller WR. (2001) The community reinforcement approach to the treatment of substance use disorders. Am J Addict 10(Suppl):51-9.
25. Sobell LC, Sobell MB. (1992) Timeline followback: A technique for assessing self-reported ethanol consumption. In Allen J, Litten RZ (eds). Measuring Alcohol Consumption: Psychosocial and Biological Methods. New Jersey: Human Press, 41-72
26. Sogliero-Gilbert G, Mosher K, Zubkoff L. (1986) A procedure for tile simplification and assessment of lab parameters in clinical trials. Drug Inf J 20:279-96.
27. World Drink Trends (2005). Productschap Voor Gedistilleerde Dranken UK: NTC Publications.